Vaccinex Change To Account Receivables from 2010 to 2024

VCNX Stock  USD 3.62  0.02  0.56%   
Vaccinex Change To Account Receivables yearly trend continues to be fairly stable with very little volatility. Change To Account Receivables is likely to outpace its year average in 2024. During the period from 2010 to 2024, Vaccinex Change To Account Receivables regression line of annual values had significance of  0.29 and arithmetic mean of (146,647). View All Fundamentals
 
Change To Account Receivables  
First Reported
2016-12-31
Previous Quarter
-20 K
Current Value
60 K
Quarterly Volatility
231.1 K
 
Covid
Check Vaccinex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaccinex's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 19.7 K or Depreciation And Amortization of 181 K, as well as many indicators such as Price To Sales Ratio of 7.19, Dividend Yield of 0.0 or Days Sales Outstanding of 451. Vaccinex financial statements analysis is a perfect complement when working with Vaccinex Valuation or Volatility modules.
  
Check out the analysis of Vaccinex Correlation against competitors.
For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.

Latest Vaccinex's Change To Account Receivables Growth Pattern

Below is the plot of the Change To Account Receivables of Vaccinex over the last few years. It is Vaccinex's Change To Account Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaccinex's overall financial position and show how it may be relating to other accounts over time.
Change To Account Receivables10 Years Trend
Slightly volatile
   Change To Account Receivables   
       Timeline  

Vaccinex Change To Account Receivables Regression Statistics

Arithmetic Mean(146,647)
Coefficient Of Variation(247.75)
Mean Deviation234,196
Median(85,000)
Standard Deviation363,314
Sample Variance132B
Range1.5M
R-Value(0.29)
Mean Square Error130.1B
R-Squared0.08
Significance0.29
Slope(23,675)
Total Sum of Squares1.8T

Vaccinex Change To Account Receivables History

2024-746.7 K
2023-786 K
2022-175 K
2021157 K
2020741 K
2019-260 K
2018-522 K

About Vaccinex Financial Statements

Vaccinex investors use historical fundamental indicators, such as Vaccinex's Change To Account Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaccinex. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change To Account Receivables-786 K-746.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vaccinex Stock Analysis

When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.